Home arrow Research
Research Center
FDA Warns About Injection Site Reactions With Naltrexone PDF Print E-mail
User Rating: / 1
Written by Emma P. Hitt, PhD   
Monday, 18 August 2008
Injectable, extended-release naltrexone (Vivitrol, Cephalon), used for the treatment of alcohol dependence, has been linked to adverse injection-site reactions, some requiring surgery, according to a US Food and Drug Administration (FDA) advisory notice to healthcare professionals released yesterday.
Read more...
 
Recurrence Rare After Prostatectomy of Organ-Confined, Lower Grade Cancer PDF Print E-mail
User Rating: / 1
Written by Ramaz Mitaishvili   
Monday, 18 August 2008
Men with organ-confined prostate cancer and a Gleason score of 6 or less very rarely have local or biochemical recurrence of disease 5 years after prostatectomy, according to study findings appearing in the July issue of Urology.
Read more...
 
Statins Help With Obesity-Related Plaque Progression After Heart Surgery PDF Print E-mail
User Rating: / 1
Written by Ramaz Mitaishvili   
Monday, 18 August 2008
As body mass index (BMI) increases, the likelihood that atherosclerosis will progress after coronary artery bypass grafting (CABG) also rises, US researchers report. However, aggressive statin therapy may eliminate this association.
Read more...
 
Russia and Georgia cyberspace war PDF Print E-mail
User Rating: / 0
Written by Administrator   
Sunday, 17 August 2008
Russia- With the current state of battle between Russia and Georgia provinces, the entire region has been very volatile.

But there have been a number of different attacks of a different nature recently, with hackers from both nations doing battle against each other in warfare of a different kind.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 29 - 32 of 607

Foundation Georgia

www.foundationgeorgia.com